Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: An experimental study on human glioblastoma cell lines

Anti-Cancer Drugs

Volumn 10, Issue 4, 1999, Pages 413-417

  Ilc, Karine ^a   Ferrero, Jean Marc ^a   Fischel, Jean Louis ^b   Formento, Patricia ^a   Bryce, Richard ^a   Etienne, Marie Christine ^b   Milano, Gérard ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b Scotia Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Fotemustine; Gamma linoleic acids; Glioblastoma; In vitro cytotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FOTEMUSTINE; GAMMA LINOLENIC ACID; LITHIUM DERIVATIVE; MEGLUMINE; NITROSOUREA DERIVATIVE; ORGANOPHOSPHORUS COMPOUND;

ARTICLE; BRAIN TUMOR; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; DRUG INTERACTION; DRUG SCREENING; GLIOBLASTOMA; HUMAN;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL SURVIVAL; DRUG INTERACTIONS; DRUG SCREENING ASSAYS, ANTITUMOR; GAMMA-LINOLENIC ACID; GLIOBLASTOMA; HUMANS; LITHIUM COMPOUNDS; MEGLUMINE; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0033109777     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199904000-00010     Document Type: Article

References (18)

1. Das UN, Huang Y-S, Begin ME, Elis G, Horrobin DF. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Rad Biol Med 1987; 3: 9-14.
2. Horrobin DF. Unsarurated lipids and cancer. In: Horrobin DF, ed. New approaches to cancer treatment. Edinburgh: Churchill Communications 1994: 3-29.
3. Dippenaar N, Booyens J, Fabbri D, Engelbvecht P, Kotzeff IE. The reversibility of cancer evidence that malignancy in melanoma cells is gamma-linolenic acid deficiency-dependent. SAfrMed 1982; 62: 505-9.
4. Begin ME, Das UN, Ells G. Cytotoxic effects of EFAs on mixed cultures of normal and malignant human cells. Prog Lipid Res 1986; 25: 573-576.
5. Falconer JS, Ross JA, Fearon KCH, et al. Effect of eicosapentaenoic acid and other fatly acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer 1994; 69: 826-32.
6. Van Der Merwe CF, Booyens J, Kateef IE. Oral gammalinolenic acid in 21 patients with untreatable malignancy. An ongoing pilot open clinical trial. BrJ Clin Prac 1987; 41: 907-15.
7. Van Der Merwe CF, Booyens J, Joubert HF, et al. The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver cancer. A double-blind placebo controlled trial. Prostaglandins Lenkotr EFAs 1990; 40: 199-202.
8. Das UN, Prasad WK, Reddy DR. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94: 147-55.
9. Fearon KCH, Falconer JS, Ross JA, et dl. An open phase I/ II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate. Anticancer Res 1996; 16: 867-74.
10. CarmichaelJ, De Graff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of tetrazolium-based semi automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-40.
11. Chou TC, Talalay P. Quantitative analysis of dose-effects relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enz Reg 1984; 22: 27-55.
12. Plumb JA, Luo W, Kerr DJ. Effect of polyunsatured fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. BrJ Cancer 1993; 67: 728-33.
13. Day RS, Ziolkowski C, Scudiero D, et al. Defective repair of alkylated DNA by human tumor and SV40 transformed human cell strains. Nature 1980; 288: 724-29.
14. 6-methylguanine DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Cardnogenesis 1991; 12: 1857-67.
15. Jiang WG, Hiscox S, Hallet MB. Inliibition of hepatocyte growtli factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. BrJ Cancer 1995; 71: 744-52.
16. Jiang WG, Bryce RP, Horrobin DF. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998; 27: 179-209.
17. Takeda S, Horrobin DF, Manku MS. Tlie effects of gamma-linolenic acid on human breast cancer cell killing, lipid peroxidation and the production of Schiff-reactive materials. MedSciRes 1992; 20: 203-5.
18. 6-alkylguanine-DNA alkyltransferase following whole body X-iradiation. Cancer Res 1986; 46: 245-9.